These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Initial methadone dose in treating opiate addiction. Wang RI; Kochar C; Hasegawa AT; Roh BL Int J Addict; 1982 Feb; 17(2):357-63. PubMed ID: 7076369 [TBL] [Abstract][Full Text] [Related]
23. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. Calsyn DA; Malcy JA; Saxon AJ J Subst Abuse Treat; 2006 Mar; 30(2):159-63. PubMed ID: 16490679 [TBL] [Abstract][Full Text] [Related]
24. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers. Lamas X; Farre M; Cami J J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958 [TBL] [Abstract][Full Text] [Related]
25. Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy. Charney DS; Riordan CE; Kleber HD; Murburg M; Braverman P; Sternberg DE; Heninger GR; Redmond DE Arch Gen Psychiatry; 1982 Nov; 39(11):1327-32. PubMed ID: 7138234 [TBL] [Abstract][Full Text] [Related]
26. Clinical utility of clonidine in opiate withdrawal: a study of 100 patients. Gold MS; Kleber HD Prog Clin Biol Res; 1981; 71():299-306. PubMed ID: 6276899 [No Abstract] [Full Text] [Related]
27. Acute physical dependence in humans: repeated naloxone-precipitated withdrawal after a single dose of methadone. Wright C; Bigelow GE; Stitzer ML; Liebson IA Drug Alcohol Depend; 1991 Mar; 27(2):139-48. PubMed ID: 1647293 [TBL] [Abstract][Full Text] [Related]
28. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Jones HE; Johnson RE; Jasinski DR; Milio L Drug Alcohol Depend; 2005 Apr; 78(1):33-8. PubMed ID: 15769555 [TBL] [Abstract][Full Text] [Related]
29. Patterns of symptom complaints in methadone maintenance patients. Dyer KR; White JM Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488 [TBL] [Abstract][Full Text] [Related]
30. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers. Mintzer MZ; Correia CJ; Strain EC Drug Alcohol Depend; 2004 May; 74(2):205-9. PubMed ID: 15099664 [TBL] [Abstract][Full Text] [Related]
31. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Rehni AK; Bhateja P; Singh TG; Singh N Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544 [TBL] [Abstract][Full Text] [Related]
32. Progress report from the NIDA Addiction Research Center, Baltimore, Maryland. Jasinski DR; Boren JJ; Henningfield JE; Johnson RE; Lange WR; Lukas SE NIDA Res Monogr; 1984 Mar; 49():69-76. PubMed ID: 6148697 [No Abstract] [Full Text] [Related]
33. Time course of repeated naloxone challenge after single morphine doses in humans. Heishman SJ; Stitzer ML NIDA Res Monogr; 1989; 95():385-6. PubMed ID: 2641004 [No Abstract] [Full Text] [Related]